These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 18056241

  • 1. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P.
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [Abstract] [Full Text] [Related]

  • 2. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC.
    Biol Psychiatry; 2007 Oct 15; 62(8):870-7. PubMed ID: 17678634
    [Abstract] [Full Text] [Related]

  • 3. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
    Selvaraj S, Murthy NV, Bhagwagar Z, Bose SK, Hinz R, Grasby PM, Cowen PJ.
    Psychopharmacology (Berl); 2011 Feb 15; 213(2-3):555-62. PubMed ID: 19756523
    [Abstract] [Full Text] [Related]

  • 4. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR, DeLorenzo C, Yang J, Mann JJ, Parsey RV.
    J Nucl Med; 2018 Apr 15; 59(4):665-670. PubMed ID: 28935838
    [Abstract] [Full Text] [Related]

  • 5. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.
    J Psychiatr Res; 2008 Oct 15; 42(14):1137-44. PubMed ID: 18331740
    [Abstract] [Full Text] [Related]

  • 6. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA.
    Arch Gen Psychiatry; 2004 Dec 15; 61(12):1271-9. PubMed ID: 15583118
    [Abstract] [Full Text] [Related]

  • 7. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC.
    Biol Psychiatry; 2006 Aug 01; 60(3):207-17. PubMed ID: 16875929
    [Abstract] [Full Text] [Related]

  • 8. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, Kosaka J, Arakawa R, Fujimura Y, Ota M, Takano A, Fukui K, Nakayama K, Suhara T.
    Neuroimage; 2010 Jan 01; 49(1):121-6. PubMed ID: 19660554
    [Abstract] [Full Text] [Related]

  • 9. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
    Meyer JH.
    J Psychiatry Neurosci; 2007 Mar 01; 32(2):86-102. PubMed ID: 17353938
    [Abstract] [Full Text] [Related]

  • 10. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G, Cannon DM, Allen AS, Klaver JM, Peck SA, Liu X, Manji HK, Drevets WC, McMahon FJ.
    Int J Neuropsychopharmacol; 2010 Jul 01; 13(6):715-24. PubMed ID: 20047709
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
    van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ.
    J Psychiatr Res; 2014 Nov 01; 58():147-54. PubMed ID: 25145808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S, Rullmann M, Luthardt J, Winter K, Hankir MK, Becker GA, Zientek F, Reissig G, Regenthal R, Drabe M, Schinke C, Bresch A, Arelin K, Lobsien D, Patt M, Meyer PM, Fasshauer M, Fenske WK, Blüher M, Stumvoll M, Sabri O.
    Eur J Nucl Med Mol Imaging; 2016 Jun 01; 43(6):1096-104. PubMed ID: 26577939
    [Abstract] [Full Text] [Related]

  • 15. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K, Solbach C, Reischl G, Schwärzler F, Gründer G, Machulla HJ, Bares R, Heinz A.
    Mol Psychiatry; 2008 Jun 01; 13(6):606-13, 557. PubMed ID: 18268503
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Meta-analysis of molecular imaging of serotonin transporters in major depression.
    Gryglewski G, Lanzenberger R, Kranz GS, Cumming P.
    J Cereb Blood Flow Metab; 2014 Jul 01; 34(7):1096-103. PubMed ID: 24802331
    [Abstract] [Full Text] [Related]

  • 18. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P, Rullmann M, Drabe M, Luthardt J, Becker GA, Blüher M, Regenthal R, Sabri O, Hesse S.
    Neuropharmacology; 2016 Nov 01; 110(Pt A):530-536. PubMed ID: 27108933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.